-
February 24, 2022 LSD Microdosing Study Finds ‘No Residual Effects’ on Mood or CognitionAnother study concludes with results challenging the increasingly popular narrative that microdosing psychedelics improves mood...
-
January 7, 2022 Is ‘The Trip’ Essential to The Psychedelic Experience?Biology and experience are tough to separate, but some researchers are exploring the possibility of...
-
January 6, 2022 Psychedelics Can Change Your View on the Nature of RealityA recent study has found that psychedelics can fundamentally change your core beliefs about the...
-
December 29, 2021 Texas Further Embraces Psychedelics with Launch of Center for Psychedelic Research and TherapyResearch will focus on how various psychedelics can be used under proper supervision and guidance...
-
December 27, 2021 Can Psychedelics Treat Alzheimer’s Disease?Since substances such as LSD and psilocybin have powerful anti-inflammatory properties, researchers argue that the...
-
December 23, 2021 FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating DisorderThe pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9...
-
December 14, 2021 Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk“HPPD is precisely the kind of risk that could fall through the cracks," says journalist...
-
December 13, 2021 Compass Pathways Study Finds SSRI Drugs Did Not Impede Psilocybin’s Therapeutic EffectChief Medical Officer Guy Goodwin calls study "a strong signal that COMP360 psilocybin therapy could...
-
December 9, 2021 Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ DerivativeFurther in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically...
-
December 8, 2021 You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study ShowsEvidence supports the idea that the possibly unpleasant nature of the psychedelic experience is an...
